Severity 1 of 5
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Severity 1 (Low) recalls are typically cosmetic defects, documentation issues, packaging-only problems, and Class III administrative corrections. The product itself is unlikely to cause adverse health consequences. The manufacturer is correcting the issue to comply with FDA or USDA rules, not because anyone is at risk. You can almost always continue using a Severity-1 product without concern.
The full rubric is on the methodology page. Severity is computed deterministically from the agency’s own classification plus the source text — no editorial vibes.
JBS USA is recalling approximately 4,922 pounds of ground chuck beef produced on July 15, 2017, due to possible contamination with shredded Styrofoam packaging.
Hospira is recalling 701 vials of Argatroban Injection because a denitroquinoline-related impurity exceeded specifications during testing.
Shionogi Inc. is recalling 455 bottles of PONSTEL capsules because stability testing showed low dissolution results.
Teva Pharmaceuticals is recalling specific lots of Buprenorphine and Naloxone Sublingual Tablets because they failed impurity specifications.
Valeant Pharmaceuticals is recalling 844 bottles of Obagi-C Rx System C-Therapy Night Cream because the bottles are missing the product insert and outer carton containing safety instructions.
Shionogi Inc. is recalling Mefenamic Acid 250mg capsules because stability testing showed low dissolution results.
Lupin Pharmaceuticals is recalling Paroxetine Extended-Release Tablets because they failed dissolution testing during stability studies.
AB Hanson and Mohring is recalling 14,238 bags of Saltwell sea salt products because they may contain pieces of foreign material.
AMS Diagnostics is recalling 9 units of Medica ISE Module Calibrant A because the lot was not functioning properly and did not exhibit correct physical properties.
Forest River is recalling 2017 Rockwood travel trailers because an incorrect check digit on the VIN label may hinder vehicle registration and safety recall tracking.
PharMEDium Services is recalling seven Bupivacaine HCl ON-Q pumps because of incorrect or missing lot and expiration dates.
PharMEDium Services is recalling two Bupivacaine HCl ON-Q pumps due to incorrect or missing lot and expiration date labeling.
PharMEDium Services, LLC is recalling 21 pumps of Ropivacaine HCl 0.2% injection due to incorrect or missing lot and expiration dates.
PharMEDium Services, LLC is recalling 10 Ropivacaine HCl 0.2% ON-Q pumps nationwide due to incorrect or missing lot and expiration dates.
Encore Medical is recalling 3DKnee Tibial Inserts because a size 6 left box contained a size 8 right insert.
PharMEDium Services is recalling 22 Ropivacaine HCl pumps nationwide because of incorrect or missing lot and expiration dates.
PharMEDium Services is recalling 79 Ropivacaine HCl IV pumps because of incorrect or missing lot and expiration dates.
PharMEDium Services is recalling 147 Ropivacaine HCl IV pumps nationwide because of incorrect or missing lot and expiration dates.
Medtest Holdings is recalling Pointe Scientific CRP calibrator and standard sets because vial labels incorrectly list units as mg/dl instead of mg/L.
CryoLife, Inc. is recalling 705 boxes of BioGlue Surgical Adhesive because 9 boxes had incorrect lot numbers on their courtesy labels.
Mckesson Packaging Services is recalling BuPROPion HCL Tablets, 75 mg, due to out-of-specification moisture content.
Medtest Holdings is recalling Pointe Scientific Liquid Creatine Kinase Reagent Sets because the product insert does not match the approved premarket notification.
Euro Diagnostica AB is recalling 501 units of DIASTAT ANA kits because the packaging displayed the original expiration date instead of the shortened one.
L. Perrigo is recalling 1,998 Walgreens Daytime and Nighttime Cold & Flu combo packs in Illinois because the packaging sleeve incorrectly identifies the contents as Day-Night Cold and Flu instead of Day-Night Cough Liquid.
Sanofi-Aventis is recalling Gaviscon chewable tablets due to high out-of-specification magnesium levels. The recall covers 2,980 bottles distributed in the US, Puerto Rico, and the UK.